B-cell Acute Lymphoblastic Leukemia

Showing 26 - 50 of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Acute Lymphoblastic Leukemia Trial in Sanhe (GC007F)

Completed
  • B-cell Acute Lymphoblastic Leukemia
  • GC007F
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Apr 21, 2022

Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in United States (PBCAR0191, Fludarabine, Cyclophosphamide)

Recruiting
  • Non-Hodgkin Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • PBCAR0191
  • +2 more
  • Duarte, California
  • +9 more
Apr 18, 2022

B-cell Acute Lymphoblastic Leukemia, Lymphoblastic B-Cell Lymphoma Trial in Minsk (CD19 CAR-T-cells, Tocilizumab)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic B-Cell Lymphoma
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Apr 12, 2022

B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Apr 4, 2022

Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • XmAb14045
  • Jacksonville, Florida
  • +8 more
Mar 4, 2022

B-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CART/CTL and DCvac)

Recruiting
  • B-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CART/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-Immune Medical Institute
Mar 7, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tampa, Florida
  • +2 more
Feb 14, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Seoul (SNUH-CD19-CAR-T)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • SNUH-CD19-CAR-T
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 20, 2022

B-cell Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • (no location specified)
Feb 3, 2022

Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
Jan 19, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

CAR T Cell Therapy Related Cardiovascular Outcomes

Recruiting
  • Cardiovascular Diseases
  • +7 more
    • London, United Kingdom
      University College London Hospitals
    Nov 18, 2021

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (UCART19)

    Completed
    • B-cell Acute Lymphoblastic Leukemia
    • UCART19
    • Boston, Massachusetts
    • +8 more
    Sep 24, 2021

    B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Milwaukee, Wisconsin
      Children's Hospital of Wisconsin
    Sep 12, 2021

    B-cell Acute Lymphoblastic Leukemia Trial in United States (NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • NGS-MRD
    • Myeloablative allogeneic HCT with a non-TBI conditioning regimen
    • Birmingham, Alabama
    • +23 more
    Aug 20, 2021

    B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Kunming (Anti-CD19 CAR-T Cells Injection)

    Recruiting
    • B Cell Lymphoma
    • B-cell Acute Lymphoblastic Leukemia
    • Anti-CD19 CAR-T Cells Injection
    • Kunming, Yunnan, China
      Kunming Yan'an Hospital
    May 12, 2021

    B-cell Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Pediatric Trial in Moscow (Chimeric Antigen Receptor T-Cell

    Unknown status
    • B-cell Acute Lymphoblastic Leukemia
    • Acute Lymphocytic Leukemia, Pediatric
    • Chimeric Antigen Receptor T-Cell Therapy
    • +3 more
    • Moscow, Russian Federation
      Dmitry Rogachev National Research Center of Pediatric Hematology
    Apr 7, 2021

    B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)

    Recruiting
    • B Cell Leukemia
    • +4 more
    • CAR-ITNK cells
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Feb 6, 2021

    B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic

    Completed
    • B Acute Lymphoblastic Leukemia
    • +3 more
    • AUTO3 (CD19/22 CAR T cells
    • London, United Kingdom
    • +2 more
    Jan 11, 2021

    B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic

    Completed
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CTL019 T-cells
    • Los Angeles, California
    • +12 more
    Oct 29, 2020

    B-cell Acute Lymphoblastic Leukemia Trial (GC019F)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • GC019F
    • (no location specified)
    Oct 14, 2020

    B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (IFN-a combined with CAR-T cell therapy)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • IFN-α combined with CAR-T cell therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Aug 28, 2020

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in ChongQing (anti-CD19 UCAR-T cells, Fludarabine, Cytoxan)

    Unknown status
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Lymphoma
    • anti-CD19 UCAR-T cells
    • +3 more
    • ChongQing, Chongqing, China
      Department of Hematology, Xinqiao Hospital
    Feb 7, 2020

    B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)

    Completed
    • B-cell Acute Lymphoblastic Leukemia
    • Graz, Austria
    • +74 more
    Jan 31, 2020